Skip to Main Content

Paper Details

Live Cell Mass Accumulation Measurement Non-Invasively Predicts Carboplatin Sensitivity in Triple-Negative Breast Cancer Patient-Derived Xenografts.
ACS Omega
7
2018
Author NameAffiliation
Joshua Chuck HarrellVirginia Commonwealth University
Joshua Chuck HarrellWright Center for Clinical and Translational Research, Virginia Commonwealth University
Joshua Chuck HarrellMassey Cancer Center, Virginia Commonwealth University, 401 College Street
Jason ReedVirginia Commonwealth University
Jason ReedMassey Cancer Center, Virginia Commonwealth University, 401 College Street
  • 1 - 5

Datasets

Release 1.2